(Q28367756)

6 July 2017

Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man (English)

1 reference

6 July 2017

Pickles H

1

1 reference

PubMed ID

7049212

6 July 2017

O'Grady J

series ordinal

2

1 reference

PubMed ID

7049212

6 July 2017

language of work or name

English

0 references

publication date

1 August 1982

1 reference

British Journal of Clinical Pharmacology

6 July 2017

1 reference

6 July 2017

14

1 reference

6 July 2017

2

1 reference

6 July 2017

177-185

1 reference

Some direct and reflex cardiovascular actions of prostacyclin (PGI2) and prostaglandin E2 in anaesthetized dogs

6 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Chlorpropamide alcohol flush and circulating met-enkephalin: a positive link

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Cigarette smoking does not attenuate the cardiovascular effects of epoprostenol (prostacyclin) in humans

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Haemodynamic effects of prostacyclin (PGI2) in pulmonary hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Prostacyclin infusion in haemolytic-uraemic syndrome of children

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Prostaglandin E1 treatment of leg ulcers caused by venous or arterial incompetence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

A double blind placebo controlled crossover study of prostacyclin in man

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Effects of prostacyclin on perfusion pressure, electrical activity, rate and force of contraction in isolated rat and rabbit hearts

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Successful therapy of advanced arteriosclerosis obliterans with prostacyclin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

The effect of clinical prostacyclin infusions in advanced arterial disease on platelet function and plasma 6-keto PGF1 alpha levels.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1427755

Effect of prostacyclin on antigfn inducfd ifowdiatf rronchoconstriction in astmatic patients

2 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01959.X

The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01959.X

Prostacyclin (PGI2) lowers heart rate in the conscious dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01959.X

Prostacyclin administration during cardiopulmonary bypass in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01959.X

Prostacyclin infusion during cardiopulmonary bypass in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01959.X

Haemodynamic changes induced by prostacyclin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01959.X

PGH2, TxA2 and PGI2 have potent and differentiated actions on human uterine contractility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01959.X

Use of prostacyclin in persistent fetal circulation

21 January 2018

1 reference

12 December 2020

Prostacyclin deficiency in thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Federation of American Societies for Experimental Biology. 64th Annual Meeting. Anaheim, California. April 13--18, 1980. Abstracts of papers. 3014--4925

1 reference

12 December 2020

Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure

1 reference

12 December 2020

Treatment of pregnancy hypertension with prostacyclin

1 reference

12 December 2020

Effects of intravenous infusion of prostacyclin (PGI2) in man

1 reference

12 December 2020

The effects of prostacyclin on glycemia and insulin release in man

1 reference

12 December 2020

Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy

1 reference

12 December 2020

Prostacyclin for acute coronary insufficiency

1 reference

12 December 2020

Prostacyclin therapy of thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Prostacyclin in central retinal vein occlusion

1 reference

12 December 2020

Intravenous prostacyclin for ischemic ulcers in peripheral artery disease

1 reference

12 December 2020

Prostacyclin for pulmonary hypertension

1 reference

12 December 2020

Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man

1 reference

12 December 2020

Prostacyclin therapy in peripheral arterial disease

1 reference

12 December 2020

The renin--kallikrein--prostaglandin system: plasma active and inactive renin and urinary kallikrein during prostacyclin infusion in man

1 reference

12 December 2020

Effects of prostacyclin on aspecifically and specifically induced bronchoconstriction in asthmatic patients

1 reference

12 December 2020

Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent

1 reference

12 December 2020

Prostacyclin and blood glucose levels in humans and rabbits

1 reference

12 December 2020

Prostacyclin does not affect insulin secretion in humans

1 reference

12 December 2020

Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels

1 reference

12 December 2020

Prostacyclin safer than heparin in haemodialysis

1 reference

12 December 2020

Effects of prostacyclin infusion in uremic patients: hematologic and hemodynamic responses

1 reference

12 December 2020

Dialysis without anticoagulants

1 reference

12 December 2020

Successful treatment of Raynaud's Syndrome with prostacyclin

1 reference

12 December 2020

The effect of infused prostacyclin in migraine and cluster headache

1 reference

12 December 2020

A double blind study of prostacyclin in cardiopulmonary bypass surgery

1 reference

12 December 2020

Prostacyclin is not a circulating hormone

1 reference

12 December 2020

Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)

1 reference

12 December 2020

10.1111/J.1365-2125.1982.TB01959.X

Identifiers

DOI

1 reference

6 July 2017

1 reference

6 July 2017

1 reference

PubMed ID

7049212